The impact of disadvantage on the development and progression of diabetic kidney disease

Clinical Nephrology

Volumn 74, Issue SUPPL.1, 2010, Pages

  Weil, E J ^a   Curtis, J M ^a   Hanson, R L ^a   Knowler, W C ^a   Nelson, R G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Diabetic nephropathy; Minorities; Obesity; Type 2 diabetes in youth

Indexed keywords

ADOLESCENT; ADULT; CHILD; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; PATHOPHYSIOLOGY; PREGNANCY; REVIEW; SOCIOECONOMICS; VULNERABLE POPULATION;

ADOLESCENT; ADULT; CHILD; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PREGNANCY; SOCIOECONOMIC FACTORS; VULNERABLE POPULATIONS;

EID: 79952277817     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. http://www.who.int/mediacentre/factsheets/fs312/en/
2. Nelson RG. Intrauterine determinants of diabetic kidney disease in disadvantaged populations. Kidney Int. 2003; 83 (Suppl): 13-16.
3. Weil EJ, Nelson RG. Diabetic Kidney Disease in Transitional and Disadvantaged Populations. In: Cortes P, Mogensen CE (eds).The Diabetic Kidney. Totowa, New Jersey: Humana Press; 2006.
4. Phipps K, Barker DJ, Hales CN, Fall CH, Osmond C, Clark PM. Fetal growth and impaired glucose tolerance in men and women. Diabetologia. 1993; 36: 225-228.
5. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C,Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991; 303: 1019-1022.
6. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993; 36: 62-67.
7. Lopes AA, Port FK. Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes. Am J Kidney Dis. 1995; 25: 714-721.
8. de Onis M, Blossner M, Villar J. Levels and patterns of intrauterine growth retardation in developing countries. Eur J Clin Nutr. 1998; 52 (Suppl): 5-15.
9. Lemley KV. A basis for accelerated progression of diabetic nephropathy in Pima Indians. Kidney Int. 2003; 83 (Suppl): 38-42.
10. Nelson RG, Morgenstern H, Bennett PH. Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus. Am J Epidemiol. 1998; 148: 650-656.
11. Singh GR, Hoy WE. Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community. Am J Kidney Dis. 2004; 43: 254-259.
12. Amri K, Freund N, Vilar J, Merlet-Benichou C, Lelievre-Pegorier M. Adverse effects of hyperglycemia on kidney development in rats: in vivo and in vitro studies. Diabetes. 1999; 48: 2240-2245.
13. Nelson RG, Morgenstern H, Bennett PH. Intrauterine diabetes exposure and the risk of renal disease in diabetic Pima Indians. Diabetes. 1998; 47: 1489-1493.
14. Merlet-Benichou C. Influence of fetal environment on kidney development. Int J Dev Biol. 1999; 43: 453-456.
15. http://www.iotf.org/childhoodobesity.asp.
16. Poskitt EM. Countries in transition: underweight to obesity non-stop? Ann Trop Paediatr. 2009; 29: 1-11.
17. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008; 93: 9-30.
18. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999; 22: 345-354.
19. Krakoff J, Lindsay RS, Looker HC, Nelson RG, Hanson RL, Knowler WC. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care. 2003; 26: 76-81.
20. Maahs DM, Snively BM, Bell RA, Dolan L, Hirsch I, Imperatore G, Linder B, Marcovina SM, Mayer-Davis EJ, Pettitt DJ, Rodriguez BL, Dabelea D. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care. 2007; 30: 2593-2598.
21. Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA. 2006; 296: 421-426.
22. Thomas M. Antecedents of renal disease in Aborigines. Nephrology (Carlton). 2004; 9: 113-116.
23. Yaqoob M, Patrick AW, McClelland P, Stevenson A, Mason H, Percy DF, White MC, Bell GM. Occupational hydrocarbon exposure and diabetic nephropathy. Diabet Med. 1994; 11: 789-793.
24. Tsaih SW, Korrick S, Schwartz J, Amarasiriwardena C, Aro A, Sparrow D, Hu H. Lead, diabetes, hypertension, and renal function: the normative aging study. Environ Health Perspect. 2004; 112: 1178-1182.
25. Biesenbach G, Grafinger P, Janko O, Zazgornik J. Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clin Nephrol. 1997; 48: 146-150.
26. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schafer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int. 1998; 54: 926-931.
27. Muhlhauser I. Cigarette smoking and diabetes: an update. Diabet Med. 1994; 11: 336-343.
28. Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J Thorac Oncol. 2008; 3: 819-831.
29. Perkins JJ, Sanson-Fisher RW, Blunden S, Lunnay D, Redman S, Hensley MJ. The prevalence of drug use in urban aboriginal communities. Addiction. 1994; 89: 1319-1331.
30. Chen X, Li X, Stanton B, Fang X, Lin D, Cole M, Liu H, Yang H. Cigarette smoking among rural-to-urban migrants in Beijing, China. Prev Med. 2004; 39: 666-673.
31. Ramachandran A, Snehalatha C, Vinitha R, Thayyil M, Kumar CK, Sheeba L, Joseph S,Vijay V. Prevalence of overweight in urban Indian adolescent school children. Diabetes Res Clin Pract. 2002; 57: 185-190.
32. Pazmino PA, Pazmino AK. Diabetic renal failure in Texas: influence of ethnicity and household income. Tex Med. 2003; 99: 57-65.
33. Brancati FL, Whelton PK, Kuller LH, Klag MJ. Diabetes mellitus, race, and socioeconomic status. A population-based study. Ann Epidemiol. 1996; 6: 67-73.
34. Hazuda HP, Haffner SM, Stern MP, Eifler CW. Effects of acculturation and socioeconomic status on obesity and diabetes in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol. 1988; 128: 1289-1301.
35. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998; 21: 518-524.
36. Ramachandran A, Snehalatha C, Vijay V, King H. Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabet Med. 2002; 19: 130-135.
37. Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care. 2003; 26: 3054-3060.
38. Kasiske BL, Rith-Najarian S, Casper ML, Croft JB. American Indian heritage and risk factors for renal injury. Kidney Int. 1998; 54: 1305-1310.
39. Krop JS, Coresh J, Chambless LE, Shahar E,Watson RL, Szklo M, Brancati FL. Acommunity-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med. 1999; 159: 1777-1783.
40. Cass A, Cunningham J, Snelling P,Wang Z, Hoy W. End-stage renal disease in indigenous Australians: a disease of disadvantage. Ethn Dis. 2002; 12: 373-378.
41. Shobhana R, Begum R, Snehalatha C, Vijay V, Ramachandran A. Patients' adherence to diabetes treatment. J Assoc Physicians India. 1999; 47: 1173-1175
42. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. Health Literacy: Report of the Council on Scientific Affairs. JAMA. 1999; 281: 552-557.
43. Georges CA, Bolton LB, Bennett C. Functional health literacy: an issue in African-American and other ethnic and racial communities. J Natl Black Nurses Assoc. 2004; 15: 1-4.
44. Schillinger D, Bindman A, Wang F, Stewart A, Piette J. Functional health literacy and the quality of physician-patient communication among diabetes patients. Patient Educ Couns. 2004; 52: 315-323.
45. Larkey LK, Hecht ML, Miller K, Alatorre C. Hispanic cultural norms for health-seeking behaviors in the face of symptoms.Health Educ Behav. 2001; 28: 65-80.
46. Mani MK. Experience with a program for prevention of chronic renal failure in India. Kidney Int. 2005; 94 (Suppl): 75-78.
47. Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med. 2004; 19: 669-675.
48. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002; 287: 2519-2527. Erratum in: JAMA 2002; 288: 46.